Sherrie Jill Divito, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stevens-Johnson Syndrome | 6 | 2024 | 244 | 2.280 |
Why?
|
Hypersensitivity, Delayed | 2 | 2024 | 490 | 1.580 |
Why?
|
Skin | 11 | 2024 | 4466 | 1.390 |
Why?
|
Dapsone | 2 | 2019 | 56 | 0.790 |
Why?
|
Dendritic Cells | 9 | 2019 | 2725 | 0.780 |
Why?
|
Focal Dermal Hypoplasia | 2 | 2016 | 8 | 0.700 |
Why?
|
Angiomatosis | 1 | 2020 | 46 | 0.690 |
Why?
|
Skin Diseases, Vascular | 1 | 2020 | 41 | 0.670 |
Why?
|
Plant Extracts | 2 | 2020 | 496 | 0.660 |
Why?
|
Leprosy | 1 | 2019 | 125 | 0.640 |
Why?
|
Immunologic Memory | 3 | 2021 | 1354 | 0.600 |
Why?
|
Skin Diseases | 2 | 2020 | 1089 | 0.600 |
Why?
|
Graft vs Host Disease | 2 | 2020 | 3026 | 0.580 |
Why?
|
T-Lymphocytes | 7 | 2021 | 10181 | 0.540 |
Why?
|
Cell Migration Assays | 1 | 2016 | 21 | 0.540 |
Why?
|
Drug Hypersensitivity | 2 | 2022 | 916 | 0.520 |
Why?
|
T-Lymphocytes, Cytotoxic | 3 | 2024 | 1765 | 0.470 |
Why?
|
Keratitis, Herpetic | 3 | 2010 | 77 | 0.450 |
Why?
|
Herpesvirus 1, Human | 4 | 2010 | 753 | 0.440 |
Why?
|
Janus Kinases | 1 | 2014 | 250 | 0.430 |
Why?
|
Antigens | 1 | 2019 | 1447 | 0.430 |
Why?
|
Bone Diseases | 1 | 2016 | 418 | 0.430 |
Why?
|
Immune Tolerance | 2 | 2019 | 2299 | 0.410 |
Why?
|
Alopecia Areata | 1 | 2014 | 127 | 0.400 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2011 | 132 | 0.370 |
Why?
|
Corneal Stroma | 2 | 2010 | 171 | 0.360 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2024 | 4550 | 0.290 |
Why?
|
Cell Cycle | 1 | 2016 | 2935 | 0.290 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2019 | 3075 | 0.270 |
Why?
|
Acute Disease | 1 | 2017 | 7268 | 0.270 |
Why?
|
Lymphocyte Activation | 5 | 2021 | 5496 | 0.260 |
Why?
|
Dermatology | 1 | 2015 | 914 | 0.250 |
Why?
|
Immune System | 3 | 2015 | 798 | 0.240 |
Why?
|
Antigen Presentation | 4 | 2019 | 1254 | 0.230 |
Why?
|
Virus Activation | 1 | 2006 | 319 | 0.230 |
Why?
|
Models, Immunological | 1 | 2006 | 513 | 0.220 |
Why?
|
CD4-Positive T-Lymphocytes | 5 | 2022 | 4353 | 0.220 |
Why?
|
Biomedical Research | 2 | 2015 | 3426 | 0.210 |
Why?
|
Virus Latency | 1 | 2006 | 362 | 0.210 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5659 | 0.200 |
Why?
|
Antigen-Presenting Cells | 2 | 2020 | 967 | 0.200 |
Why?
|
Interleukin-15 | 2 | 2017 | 183 | 0.190 |
Why?
|
Skin Neoplasms | 3 | 2023 | 5799 | 0.190 |
Why?
|
Drug Eruptions | 1 | 2024 | 335 | 0.190 |
Why?
|
Animals | 23 | 2024 | 167960 | 0.180 |
Why?
|
HLA Antigens | 2 | 2023 | 1368 | 0.180 |
Why?
|
Cell Proliferation | 1 | 2016 | 10442 | 0.170 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5640 | 0.170 |
Why?
|
Exosomes | 2 | 2016 | 423 | 0.170 |
Why?
|
Eosinophilia | 1 | 2024 | 559 | 0.160 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2018 | 71 | 0.150 |
Why?
|
Interferon-gamma | 4 | 2020 | 3157 | 0.150 |
Why?
|
HLA-B Antigens | 1 | 2019 | 331 | 0.150 |
Why?
|
Mice | 16 | 2024 | 81209 | 0.150 |
Why?
|
Mice, Inbred NOD | 2 | 2020 | 1837 | 0.150 |
Why?
|
Humans | 32 | 2024 | 760613 | 0.140 |
Why?
|
Disease Models, Animal | 2 | 2015 | 18137 | 0.140 |
Why?
|
Isoantigens | 2 | 2010 | 552 | 0.140 |
Why?
|
Mice, SCID | 2 | 2020 | 2627 | 0.140 |
Why?
|
Mice, Inbred BALB C | 6 | 2016 | 6216 | 0.140 |
Why?
|
Mycosis Fungoides | 1 | 2018 | 168 | 0.140 |
Why?
|
Mice, Inbred C3H | 3 | 2016 | 915 | 0.130 |
Why?
|
Melanoma | 2 | 2011 | 5697 | 0.130 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2017 | 393 | 0.120 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 2015 | 85 | 0.120 |
Why?
|
Nails | 1 | 2016 | 295 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1792 | 0.120 |
Why?
|
Interleukin-17 | 1 | 2020 | 910 | 0.120 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2020 | 1259 | 0.110 |
Why?
|
Graft Rejection | 4 | 2016 | 4426 | 0.110 |
Why?
|
Pemphigus | 1 | 2014 | 116 | 0.110 |
Why?
|
Research | 1 | 2022 | 1974 | 0.110 |
Why?
|
Hypersensitivity | 1 | 2022 | 1155 | 0.110 |
Why?
|
Frameshift Mutation | 1 | 2015 | 388 | 0.110 |
Why?
|
T-Lymphocyte Subsets | 1 | 2021 | 1810 | 0.110 |
Why?
|
Hair | 1 | 2016 | 497 | 0.110 |
Why?
|
Chlorhexidine | 1 | 2014 | 160 | 0.110 |
Why?
|
Sirolimus | 1 | 2020 | 1547 | 0.100 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1399 | 0.100 |
Why?
|
Mice, Transgenic | 3 | 2015 | 9530 | 0.100 |
Why?
|
Mosaicism | 1 | 2015 | 466 | 0.100 |
Why?
|
Receptors, Tachykinin | 1 | 2011 | 25 | 0.100 |
Why?
|
Anti-Infective Agents, Local | 1 | 2014 | 247 | 0.100 |
Why?
|
Cytokines | 4 | 2017 | 7344 | 0.100 |
Why?
|
Tachykinins | 1 | 2011 | 77 | 0.090 |
Why?
|
Nociceptors | 1 | 2015 | 457 | 0.090 |
Why?
|
Catheter-Related Infections | 1 | 2014 | 273 | 0.090 |
Why?
|
Psoriasis | 2 | 2017 | 940 | 0.090 |
Why?
|
Transplantation | 1 | 2012 | 218 | 0.090 |
Why?
|
Interleukin-12 Subunit p35 | 1 | 2010 | 21 | 0.090 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2010 | 57 | 0.090 |
Why?
|
Angiogenesis Inhibitors | 1 | 2020 | 2049 | 0.080 |
Why?
|
Endosomes | 1 | 2011 | 519 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2020 | 3484 | 0.080 |
Why?
|
Antimalarials | 1 | 2015 | 906 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2511 | 0.080 |
Why?
|
Transplantation, Homologous | 3 | 2016 | 4815 | 0.080 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1902 | 0.080 |
Why?
|
Chemokine CCL4 | 1 | 2008 | 126 | 0.080 |
Why?
|
Infant | 2 | 2023 | 36053 | 0.080 |
Why?
|
Cell Division | 1 | 2016 | 4463 | 0.080 |
Why?
|
Autoimmune Diseases | 2 | 2019 | 2250 | 0.080 |
Why?
|
Galectin 1 | 1 | 2009 | 128 | 0.080 |
Why?
|
Nervous System | 1 | 2011 | 543 | 0.080 |
Why?
|
Cytoplasmic Vesicles | 1 | 2008 | 73 | 0.080 |
Why?
|
Female | 15 | 2024 | 391246 | 0.070 |
Why?
|
Injections, Intravenous | 1 | 2010 | 1385 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2023 | 4024 | 0.070 |
Why?
|
Adult | 8 | 2024 | 220007 | 0.070 |
Why?
|
Child, Preschool | 2 | 2023 | 42056 | 0.070 |
Why?
|
Organ Transplantation | 2 | 2015 | 1150 | 0.070 |
Why?
|
Cell Transplantation | 1 | 2009 | 472 | 0.070 |
Why?
|
Genetic Testing | 1 | 2020 | 3531 | 0.070 |
Why?
|
Neurons | 1 | 2006 | 9424 | 0.070 |
Why?
|
Flow Cytometry | 4 | 2012 | 5869 | 0.070 |
Why?
|
Male | 9 | 2024 | 359718 | 0.070 |
Why?
|
Middle Aged | 7 | 2024 | 220359 | 0.070 |
Why?
|
DNA Primers | 1 | 2010 | 2818 | 0.060 |
Why?
|
Dogs | 1 | 2010 | 3841 | 0.060 |
Why?
|
Neuropeptides | 1 | 2011 | 943 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3617 | 0.060 |
Why?
|
Early Diagnosis | 1 | 2010 | 1180 | 0.060 |
Why?
|
Prospective Studies | 2 | 2020 | 54306 | 0.060 |
Why?
|
Cell Communication | 1 | 2011 | 1653 | 0.060 |
Why?
|
Mast Cells | 1 | 2011 | 1390 | 0.060 |
Why?
|
Transplantation Tolerance | 1 | 2009 | 605 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2023 | 58980 | 0.050 |
Why?
|
Herpes Simplex | 1 | 2006 | 478 | 0.050 |
Why?
|
Child | 2 | 2023 | 79799 | 0.050 |
Why?
|
Adolescent | 2 | 2023 | 87809 | 0.050 |
Why?
|
Acetamides | 1 | 2023 | 256 | 0.050 |
Why?
|
Spleen | 3 | 2016 | 2298 | 0.050 |
Why?
|
Tissue Donors | 1 | 2010 | 2314 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2010 | 14374 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13627 | 0.040 |
Why?
|
Delphi Technique | 1 | 2024 | 829 | 0.040 |
Why?
|
Mice, Inbred C57BL | 4 | 2016 | 22020 | 0.040 |
Why?
|
Young Adult | 3 | 2023 | 58748 | 0.040 |
Why?
|
Research Design | 1 | 2016 | 6180 | 0.040 |
Why?
|
Cornea | 1 | 2007 | 1326 | 0.040 |
Why?
|
Base Sequence | 1 | 2010 | 12444 | 0.040 |
Why?
|
Neutrophils | 2 | 2010 | 3767 | 0.040 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2005 | 831 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2015 | 7850 | 0.040 |
Why?
|
Inflammation | 2 | 2022 | 10755 | 0.040 |
Why?
|
Skin Transplantation | 2 | 2016 | 1083 | 0.040 |
Why?
|
Vaccinia | 1 | 2017 | 71 | 0.030 |
Why?
|
Fibroblasts | 1 | 2007 | 4089 | 0.030 |
Why?
|
Chronic Disease | 1 | 2011 | 9288 | 0.030 |
Why?
|
HIV Infections | 1 | 2022 | 17165 | 0.030 |
Why?
|
Heart Transplantation | 3 | 2016 | 3224 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2009 | 3149 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2023 | 80345 | 0.030 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2018 | 209 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2020 | 680 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 25941 | 0.030 |
Why?
|
MicroRNAs | 1 | 2011 | 3787 | 0.030 |
Why?
|
Apoptosis | 2 | 2009 | 9497 | 0.030 |
Why?
|
Aged | 4 | 2023 | 169143 | 0.030 |
Why?
|
Vaccinia virus | 1 | 2017 | 331 | 0.030 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2017 | 296 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2020 | 805 | 0.030 |
Why?
|
Clone Cells | 1 | 2018 | 1663 | 0.030 |
Why?
|
Transplants | 1 | 2016 | 206 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2009 | 3454 | 0.030 |
Why?
|
Mycobacterium tuberculosis | 1 | 2005 | 1903 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 3113 | 0.030 |
Why?
|
Acyltransferases | 1 | 2015 | 305 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1433 | 0.030 |
Why?
|
Major Histocompatibility Complex | 1 | 2016 | 928 | 0.030 |
Why?
|
Methylprednisolone | 1 | 2014 | 384 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2022 | 2536 | 0.030 |
Why?
|
Pyrazoles | 1 | 2023 | 1999 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2010 | 11481 | 0.030 |
Why?
|
Mycophenolic Acid | 1 | 2014 | 343 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3802 | 0.030 |
Why?
|
Bandages | 1 | 2014 | 270 | 0.030 |
Why?
|
Biological Transport | 1 | 2017 | 2086 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2222 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2022 | 3047 | 0.020 |
Why?
|
Immunosuppressive Agents | 2 | 2014 | 4167 | 0.020 |
Why?
|
Membrane Fusion | 1 | 2011 | 266 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2012 | 822 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1832 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2012 | 1763 | 0.020 |
Why?
|
Cross-Priming | 1 | 2009 | 75 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2009 | 412 | 0.020 |
Why?
|
Models, Animal | 1 | 2015 | 2117 | 0.020 |
Why?
|
Cytosol | 1 | 2011 | 887 | 0.020 |
Why?
|
Signal Transduction | 1 | 2011 | 23374 | 0.020 |
Why?
|
Lymphocyte Depletion | 1 | 2010 | 602 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3302 | 0.020 |
Why?
|
Mice, Inbred A | 1 | 2007 | 246 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5797 | 0.020 |
Why?
|
Graft Survival | 1 | 2016 | 3795 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2014 | 2145 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2007 | 780 | 0.020 |
Why?
|
Th1 Cells | 1 | 2010 | 1032 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3612 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12159 | 0.010 |
Why?
|
Cell Movement | 1 | 2016 | 5206 | 0.010 |
Why?
|
Registries | 1 | 2020 | 8458 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2007 | 1351 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3774 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8512 | 0.010 |
Why?
|
Insulin-Secreting Cells | 1 | 2009 | 907 | 0.010 |
Why?
|
Critical Illness | 1 | 2014 | 2709 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 2016 | 4214 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12968 | 0.010 |
Why?
|
Survival Analysis | 1 | 2011 | 10185 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29661 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12531 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 13451 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9406 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 17624 | 0.010 |
Why?
|
Disease Progression | 1 | 2010 | 13505 | 0.010 |
Why?
|
Lung | 1 | 2005 | 9994 | 0.000 |
Why?
|